Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
| Conditions: | Pleural Mesothelioma |
| Start Date: | February 1, 2008 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00859495 |
| Study Type: | Interventional |
| Intervention: | Drug: Doxorubicin and cisplatin (intrapleural) + cisplatin and pemetrexed (systemic)|Drug: Cisplatin and doxorubicin (intrapleural) |
| Study Design: | Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Columbia University |
| Ages: | Adult|Senior |
| Enrollment: | 48 |
| Funded By: | Other |
| First Received: | March 9, 2009 |
| End Date: | December 1, 2014 |
| Last Updated: | October 13, 2010 |
| Last Verified: | October 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
